Why We Share Research
At Spore & Sage, curiosity and evidence guide our approach to cultivation. Mushrooms are biologically complex organisms that continue to be studied by researchers around the world. We share selected peer-reviewed articles and government summaries here to provide context about what scientists are exploring — not to make medical claims, but to encourage informed learning and thoughtful engagement with emerging research.
Government & Institutional Overviews
National Cancer Institute (NCI) – Medicinal Mushrooms PDQ®
This evidence-based summary from the National Cancer Institute reviews what is currently known about medicinal mushrooms and cancer. It explains that compounds in mushrooms such as reishi, turkey tail, and shiitake have been studied in laboratory and clinical settings, particularly for their interactions with immune cells. While some studies — especially outside the United States — suggest potential supportive roles alongside conventional therapies, the evidence remains limited and not conclusive. The NCI emphasizes that medicinal mushrooms are not part of standard cancer care in the United States based on current evidence.
Laboratory Research (In Vitro & Preclinical Studies)
Turkey Tail and Immune Cell Activation
Conducted by Dr. Daniel L. Sliva and colleagues at Indiana University Health Methodist Hospital and Indiana University School of Medicine, this laboratory study examined how Turkey Tail mushroom (Trametes versicolor) influences immune cells under controlled lab conditions. Researchers compared the fungal mycelium and the fermented grain substrate on which it was grown. They found that the mycelium directly activated certain immune cells, while the fermented substrate stimulated immune signaling molecules (cytokines). These findings were observed in vitro (in a laboratory setting, not in people).
Beta-Glucans and Immune Signaling
This peer-reviewed review article examines beta-glucans — naturally occurring polysaccharides found in mushrooms — and their interaction with immune cell receptors. Laboratory and animal studies show that beta-glucans can influence immune signaling pathways. Early human data suggest measurable immune marker changes, but larger clinical trials are needed to determine clear health outcomes.
Reishi Bioactive Compounds (Preclinical Research)
This review summarizes laboratory and animal research on Ganoderma lucidum (reishi), describing bioactive compounds that have demonstrated antioxidant and immune-modulating activity in preclinical models. The authors emphasize that while laboratory findings are promising, clinical evidence in humans remains limited.
Clinical Research (Human Studies)
Turkey Tail in Breast Cancer Recovery
In a small pilot clinical study conducted at the University of Minnesota, researchers evaluated the safety and immune effects of Turkey Tail extract in women recovering from breast cancer treatment. The supplement was well tolerated and associated with measurable changes in certain immune cell populations. The authors describe the findings as preliminary and recommend larger trials.
PSK (Turkey Tail Extract) and Gastric Cancer
This clinical research from Japan examined a mushroom-derived compound (PSK, extracted from Turkey Tail) used alongside chemotherapy in patients with gastric cancer. Some studies reported improved survival outcomes when used as adjuvant therapy. These findings are based largely on Japanese treatment protocols and require further study for broader application.
Maitake and Immune Function
This early clinical study examined maitake mushroom extract in cancer patients and observed changes in immune parameters such as natural killer cell activity. The authors note variability in responses and emphasize that more structured clinical trials are necessary.